ArticleCancer immunology, immunotherapy : CII2024

Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapy.

Jhen-Yu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.